RxDoctor Payments Data

Kyle Bloomfield, APRN

Acute Care · Lexington, KYNPI 1003446667

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 28.5% of the total. 2025 is the largest year on record at $845, 2.7 times the $316 reported in 2021. Among acute care clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,175in general payments, 2019–2025

Across 171 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$906
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$865
  • Sanofi$345
  • Johnson & Johnson$309
  • Takeda Pharmaceuticals U.S.A., Inc.$197
  • Intercept Pharmaceuticals, Inc.$98
  • plus $456 from 15 others

What the payments were for

  • Food & beverage$3,175100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,175 in reported general payments places this provider in the 90th percentile of 319 acute care providers in Kentucky.

See all acute care providers in Kentucky

Medicare billing

Part B allowed, 2024
$44,641
Medicare patients
296
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium26$430

Paid to pharmacies, not to this prescriber.

Other acute care in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →